Verinata Health, Inc. Patent Application Trends in 2024
Revision as of 15:42, 19 October 2024 by Wikipatents (talk | contribs) (Updating Verinata Health, Inc._Patent_Application_Trends_in_2024)
Contents
Verinata Health, Inc. Patent Filing Activity
Verinata Health, Inc. patent applications in 2024
Top 10 Technology Areas
- C12Q1/6883 (for diseases caused by alterations of genetic material)
- C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay ()
- C12Q1/6809 (Methods for determination or identification of nucleic acids involving differential detection)
- C12Q1/6869 (Methods for sequencing)
- G16B30/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
- G16H50/30 (for calculating health indices; for individual health risk assessment)
- G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids)
- G16H50/20 (for computer-aided diagnosis, e.g. based on medical expert systems)
- C12Q1/6886 (for cancer (immunoassay for cancer)
- C12Q2600/106 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
Emerging Technology Areas
- G16H10/40 (for data related to laboratory analysis, e.g. patient specimen analysis)
- G16B20/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
- C12Q2600/156 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- Count: 1 patents
- Example: 20240141424. FETAL ANEUPLOIDY DETECTION BY SEQUENCING simplified abstract (Verinata Health, Inc.)
- C12Q1/6874 (involving nucleic acid arrays, e.g. sequencing by hybridisation)
- Count: 1 patents
- Example: 20240141424. FETAL ANEUPLOIDY DETECTION BY SEQUENCING simplified abstract (Verinata Health, Inc.)
- C12Q2600/106 (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay)
- C12Q1/6886 (for cancer (immunoassay for cancer)
- G16H50/20 (for computer-aided diagnosis, e.g. based on medical expert systems)
- G16B30/00 (ICT specially adapted for sequence analysis involving nucleotides or amino acids)
- G16H50/30 (for calculating health indices; for individual health risk assessment)
- G16B30/10 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
Top Inventors
- Richard P. Rava of Redwood City CA (US) (2 patents)
- Brian K. Rhees of Gilbert AZ (US) (1 patent)
- Roland Stoughton of The Sea Ranch CA (US) (1 patent)
- Ravi Kapur of Sharon MA (US) (1 patent)
- Barb Ariel Cohen of Watertown MA (US) (1 patent)
- Mehmet Toner of Charlestown MA (US) (1 patent)
- Manjula Chinnappa of Foster City CA (US) (1 patent)
- David A. Comstock of Sunnyvale CA (US) (1 patent)
- Gabrielle Heilek of Mountain View CA (US) (1 patent)
- Brian Kent Rhees of Chandler AZ (US) (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
